| Name | Title | Contact Details |
|---|---|---|
Derek Arrison |
Senior Director of Tax and Treasury | Profile |
Scott Howell |
VP and Chief People Officer | Profile |
Capstan Therapeutics is a biotechnology company dedicated to advancing in vivo cell reprogramming. The core platform technology comprises proprietary targeted lipid nanoparticles conjugated with a recombinant protein binder such as monoclonal antibodies (tLNPs) designed to deliver payloads, including mRNA or gene editing tools, that can reprogram specific cell types in vivo. The platform technology has the potential to generate transformative therapies with applications across a broad range of disease areas, including oncology, autoimmune disorders, fibrosis, and monogenic blood disorders.
Oxford Finance Corporation is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.
Oragenics is a publicly-traded biopharmaceutical company with a pipeline of unique proprietary technologies.
13Therapeutics Inc is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
NCG Medical Systems is a Altamonte Springs, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.